Pharmacokinetic modulating chemotherapy (PMC) of 5-fluorouracil plus oxaliplatin in the treatment of unresectable metastatic colorectal carcinoma patients: A phase II study

被引：0
|
作者：
Wang, W. S.
Chiou, T. J.
Liu, J. H.
Yen, C. C.
Chao, T. C.
Lin, T. C.
Chen, W. S.
Jiang, J. K.
Yang, S. H.
Chen, P. M.
机构：
[1] Dept Med, Div Hematol & Oncol, Taipei, Taiwan
[2] Dept Surg, Div Colorectal Surg, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients
    Si Sun
    Lei Ping Wang
    Jian Zhang
    Xiao Yan Yang
    Qun Ling Zhang
    Zhen Jia
    Xi Chun Hu
    Bi Yun Wang
    Medical Oncology, 2012, 29 : 418 - 424
  • [2] Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients
    Sun, Si
    Wang, Lei Ping
    Zhang, Jian
    Yang, Xiao Yan
    Zhang, Qun Ling
    Jia, Zhen
    Hu, Xi Chun
    Wang, Bi Yun
    MEDICAL ONCOLOGY, 2012, 29 (02) : 418 - 424
  • [3] A PHASE-II AND PHARMACOKINETIC STUDY OF 6S-LEUCOVORIN PLUS 5-FLUOROURACIL IN PATIENTS WITH COLORECTAL-CARCINOMA
    MEROPOL, NJ
    PETRELLI, NJ
    RUSTUM, YM
    RODRIQUEZBIGAS, M
    BLUMENSON, LE
    FRANK, C
    BERGHORN, E
    CREAVEN, PJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (02) : 149 - 155
  • [4] A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal Cancer
    Fischer, GeorgeA.
    Kuo, Timothy
    Ramsey, Meghan
    Schwartz, Erich
    Rouse, RobertV.
    Cho, Cheryl D.
    Halsey, Joanne
    Sikic, Branimir I.
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7074 - 7079
  • [5] Multicentre phase II study of leucovorin plus pharmacokinetic modulating chemotherapy for metastatic colorectal cancer
    Inoue, Yasuhiro
    Tanaka, Koji
    Hiro, Junichiro
    Toiyama, Yuji
    Miki, Chikao
    Kusunoki, Masato
    ONCOLOGY LETTERS, 2010, 1 (01) : 81 - 85
  • [6] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [7] Oxaliplatin, UFT and oral leucovorin combination chemotherapy in 5-fluorouracil refractory colorectal carcinoma: A phase II study.
    Ryoo, HM
    Bae, SH
    Lee, HI
    Lee, JL
    Lee, KH
    Hyun, M
    Park, KU
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [8] A PHASE-II STUDY OF CHEMOTHERAPY OF METASTATIC COLORECTAL-CARCINOMA WITH 5-FLUOROURACIL PLUS CISPLATIN - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    WHITEHEAD, RP
    FLEMING, TR
    MACDONALD, JS
    AHMANN, FR
    GAREWAL, HS
    KUEBLER, JP
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (04) : 345 - 347
  • [9] A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
    Carlsson, G.
    Koumarianou, A.
    Guren, T. K.
    Haux, J.
    Katsaounis, P.
    Kentepozidis, N.
    Pfeiffer, P.
    Braendengen, M.
    Mavroudis, D.
    Taffin, H.
    Skintemo, L.
    Tell, R.
    Papadimitriou, C.
    ESMO OPEN, 2022, 7 (05)
  • [10] CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY IN ADVANCED AND OR METASTATIC COLORECTAL-CARCINOMA - A PHASE-II STUDY
    GALLIGIONI, E
    CANOBBIO, L
    FIGOLI, F
    FASSIO, T
    FRUSTACI, S
    CRIVELLARI, D
    VACCHER, E
    RE, GL
    GASPARINI, G
    VERONESI, A
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06): : 657 - 661
12345